You are here

  • Home
  • Archive
  • Volume 24, Issue Suppl 1
  • CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy

Alerts

Article menu
Download PDFPDF
Clinical pharmacy
CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address